We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




DNA Analysis Clarifies Ancestry of Triple-Negative Breast Cancer Patients

By LabMedica International staff writers
Posted on 04 Oct 2016
Print article
Image: A scanning electron micrograph (SEM) of two mitochondria from mammalian lung tissue displaying their matrix and membranes (Photo courtesy of Wikimedia Commons).
Image: A scanning electron micrograph (SEM) of two mitochondria from mammalian lung tissue displaying their matrix and membranes (Photo courtesy of Wikimedia Commons).
Age of onset and severity of triple-negative breast cancer are related to ethnic origin, which can be definitively established by analysis of mitochondrial DNA.

Triple-negative breast cancer (TNBC) lacks estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2)/neu receptors, and is aggressive and difficult to treat. Patients with TNBC tend to be younger and are more likely to be African-American. However, between 10 and 30% of Americans may not be aware of a mixed ancestry that increases their susceptibility to the disease.

Mitochondrial DNA (mtDNA), which is distinct from nuclear DNA, is maternally inherited and allows for origin determination. To assess the value of mtDNA profiling to establish ethnic origin in TNBC patients, investigators at the University of Texas Southwestern Medical Center (Dallas, USA) examined 92 patients: 31 self-described as African-American, 31 self-described as White, and 30 self-described as Hispanic.

Results revealed that Hispanic patients had largest tumor size and youngest age of onset among the three groups. However, there was a discrepency between mtDNA analysis and self-described ethnicity in 13% of the 92 patients. The highest discordance (26%; eight patients) was noted in self-described Hispanic patients: three had Nigerian ancestry, and one individual demonstrated haplogroup K mtDNA (Ashkenazi Jewish ancestry).

“We found 12 differences among 92 patients, a significant amount,” said senior author Dr. Roshni Rao, associate professor of surgery at the University of Texas Southwestern Medical Center. “Some patients who self-identified as Hispanic had African-American ancestry. One Hispanic woman was found to be Ashkenazi Jewish. Both African-Americans and some Ashkenazi Jewish populations have a higher risk for triple negative breast cancer. “If you know your ancestry, then you could be included in the group that gets screened at a younger age.”

The study was published in the September 1, 2016, online edition of the journal Cancer.

Related Links:
University of Texas Southwestern Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.